Approval of cold sore treatment in Canada expected in early 2002, Avanir CEO Gerald Yakatan, PhD, tells investors Dec. 18. Firm also is working with licensees to advance regulatory approvals in Korea, Israel, has signed letters of intent to license drug in China, Southern Europe, Middle East. Firm reports $5 mil. milestone payment, $774,000 in royalties from U.S. licensee GSK in fiscal fourth quarter ended Sept. 30. For full year, milestone payments, royalties totaled $20 mil. and $2.5 mil., respectively, San Diego-based biopharmaceutical firm says...
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?